Haemonetics Corporation HAE
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 46.31M | 33.01M | -20.15M | 44.74M | 38.68M |
| Total Depreciation and Amortization | 27.76M | 27.11M | 21.22M | 27.39M | 28.26M |
| Total Amortization of Deferred Charges | -- | -- | 6.10M | -- | -- |
| Total Other Non-Cash Items | 15.96M | 12.21M | 69.84M | 9.63M | 18.29M |
| Change in Net Operating Assets | 38.08M | -20.00M | -6.07M | 11.81M | 26.09M |
| Cash from Operations | 128.10M | 52.32M | 70.94M | 93.56M | 111.32M |
| Capital Expenditure | -14.77M | -7.91M | -17.66M | -6.35M | -5.02M |
| Sale of Property, Plant, and Equipment | 576.00K | 237.00K | 526.00K | 432.00K | 120.00K |
| Cash Acquisitions | -- | -- | -60.18M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.09M | -14.57M | -9.30M | -23.55M | -25.57M |
| Cash from Investing | -24.29M | -22.23M | -86.61M | -29.47M | -30.47M |
| Total Debt Issued | -- | -- | 300.00M | -- | -- |
| Total Debt Repaid | -51.56M | -51.56M | -301.56M | -1.56M | -1.56M |
| Issuance of Common Stock | 1.95M | 3.55M | 122.00K | 3.77M | 63.00K |
| Repurchase of Common Stock | -388.00K | -3.50M | -100.05M | -160.00K | -75.01M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.61M | -14.00K | -13.00K | -14.00K | -39.00K |
| Cash from Financing | -67.61M | -51.53M | -101.50M | 2.03M | -76.55M |
| Foreign Exchange rate Adjustments | 1.13M | -617.00K | -756.00K | 810.00K | -773.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.33M | -22.06M | -117.93M | 66.94M | 3.53M |